Literature DB >> 12752232

Epidemiology of gonadal germ cell cancer in males and females.

Henrik Møller1, Helen Evans.   

Abstract

The epidemiology of testicular germ cell cancer is relatively well understood, but less is known about the epidemiology of ovarian germ cell cancer. Cases of testicular (7910) and ovarian (453) germ cell cancer diagnosed 1960-1999 were extracted from the Thames Cancer Registry. The incidence rate in males doubled in the period from 2.0 to 4.4 per 100,000. In females the rate was much lower but the rate of increase over the period was similar to the increase in males. In both sexes the incidence increased sharply around the age of onset of puberty and decreased in older age groups. The biological mechanism of initiation of germ cell carcinogenesis is similar in males and females and probably occurs with roughly the same frequency in the two sexes. In males, the initiated cell population is promoted by the normal action of adult sex hormones to form carcinoma in situ, consisting of many millions of cells. The incidence of testicular cancer is rate limited by the development of carcinoma in situ. The key difference between males and females, which may explain the different levels of incidence, is the much lower number of susceptible cells in females at the time of puberty.

Entities:  

Mesh:

Year:  2003        PMID: 12752232     DOI: 10.1034/j.1600-0463.2003.11101071.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  18 in total

1.  Intratubular transplantation as a strategy for establishing animal models of testicular germ cell tumours.

Authors:  Yunmin Li; Tatsuo Kido; Jinping Luo; Michiko Fukuda; Ina Dobrinski; Yun-Fai Chris Lau
Journal:  Int J Exp Pathol       Date:  2008-10       Impact factor: 1.925

2.  Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006.

Authors:  Jenny N Poynter; James F Amatruda; Julie A Ross
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

3.  The impact of early and successful orchidopexy on hormonal follow-up for 208 boys with bilateral non-syndromic cryptorchidism.

Authors:  Simone Hildorf; Dina Cortes; Erik Clasen-Linde; Magdalena Fossum; Jorgen Thorup
Journal:  Pediatr Surg Int       Date:  2021-01-09       Impact factor: 1.827

4.  Sex ratio among childhood cancers by single year of age.

Authors:  Lindsay A Williams; Michaela Richardson; Erin L Marcotte; Jenny N Poynter; Logan G Spector
Journal:  Pediatr Blood Cancer       Date:  2019-02-28       Impact factor: 3.167

5.  Primary omental yolk sac tumor.

Authors:  Seon Hwa Lim; Yon Hee Kim; Ga Won Yim; Eun Ji Nam; Young Tae Kim; Sunghoon Kim
Journal:  Obstet Gynecol Sci       Date:  2013-11-15

6.  Gonadal and extragonadal germ cell tumours in the United States, 1973-2007.

Authors:  A Stang; B Trabert; N Wentzensen; M B Cook; C Rusner; J W Oosterhuis; K A McGlynn
Journal:  Int J Androl       Date:  2012-02-09

7.  Clinical aspects of histological and hormonal parameters in boys with cryptorchidism: Thesis for PhD degree.

Authors:  Simone Engmann Hildorf
Journal:  APMIS       Date:  2022-07       Impact factor: 3.428

8.  Incidence of intracranial germ cell tumors by race in the United States, 1992-2010.

Authors:  Jenny N Poynter; Rachel Fonstad; Jakub Tolar; Logan G Spector; Julie A Ross
Journal:  J Neurooncol       Date:  2014-08-03       Impact factor: 4.130

Review 9.  A mini-review of familial ovarian germ cell tumors: an additional manifestation of the familial testicular germ cell tumor syndrome.

Authors:  Claudia Giambartolomei; Christine M Mueller; Mark H Greene; Larissa A Korde
Journal:  Cancer Epidemiol       Date:  2009-05-30       Impact factor: 2.984

10.  Testicular microlithiasis heralding mixed germ cell tumor of the testis in a boy.

Authors:  T Arrigo; M F Messina; M Valenzise; M Rosano; R Alaggio; G Cecchetto; G Zirilli; F De Luca
Journal:  J Endocrinol Invest       Date:  2006-01       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.